Joshua Arbesman MD
Associate Staff, Departments of Dermatology and Cancer Biology, Cleveland Clinic, Cleveland, OhioJoshua Arbesman, MD, is a physician-scientist in the Departments of Dermatology and Cancer Biology at Cleveland Clinic. He received his undergraduate degree from Brandeis University with degrees in history and biology and attended medical school at University at Buffalo School of Medicine. Dr. Arbesman completed his residency in Dermatology at University Hospitals/Case Medical Center as part of the academic research track. He currently conducts research in the areas of melanoma germline genetics.
Recent Contributions to PracticeUpdate:
- Treatment of Cutaneous Squamous Cell Carcinoma In Situ and the Impact of Clinical Risk Factors and Positive Histologic Margins at the Time of Diagnosis
- Association of Immune-Related Adverse Events With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
- Statins Modify Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma
- Melanocytic Nevi Excised During BRAF Inhibitor Therapy
- Immunosuppression Associated With Aggressive Cutaneous Melanoma
- AAD 2015 Annual Meeting: Dr. Josh Arbesman's Take-Aways
- Modern Dermatology Practice: More Than One Way to Do It Right—Part 3
- Modern Dermatology Practice: More Than One Way to Do It Right—Part 2
- Modern Dermatology Practice: More Than One Way to Do It Right—Part 1
- Risk of Primary Melanoma Increased After Primary Invasive or In Situ Melanoma